The Power of Whole Genome Sequencing
Establishing a rapid and reliable diagnosis for complex cases can be difficult, even for the most skilled physicians. But thanks to the latest technologies and scientific insights into rare and neurodegenerative diseases, this no longer has to be the case!
Throughout the webinar, CENTOGENE’s Dr. Aida Bertoli-Avella and Dr. Tobias Böttcher share how WGS has become the first-line diagnostic test and how NEW CentoGenome integrates the latest disease-causing variants to provide you with maximized coverage – ending your patients’ diagnostic odyssey and paving the way to precision medicine.
What Will You Learn?
- Diagnostic Challenges
- Your First-Line Test for Maximized Coverage
- Uncovering the Most Variants
- Proven Patient Cases
Our Speakers
Aida M. Bertoli-Avella, M.D., PhD
Head of Research Data Analysis, CENTOGENE
Aida graduated from the Institute of Medical Sciences, Santiago de Cuba. In 2004, she […]
Tobias Böttcher, M.D.
Director Clinical Neurogenetics, CENTOGENE
Tobias Boettcher completed his internship in Neurology at the Dept. of Neurology, […]